Form 4: Amgen SVP Derek Miller Reports Stock Disposition

Amgen Inc. SVP of Human Resources Derek Miller reported the disposition of 365 shares of common stock to cover tax obligations.

Summary

• Derek Miller, SVP of Human Resources at Amgen Inc., disposed of 365 shares of common stock on May 2, 2026.
• The shares were disposed of in two transactions of 167 and 198 shares respectively.
• The transaction price was $329.82 per share.
• The disposition was executed to satisfy tax withholding obligations related to the vesting of equity awards.
• Following these transactions, the reporting person maintains a beneficial ownership of 11,808 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a strategic shift or market-driven sale.

Positives

• The transaction is a routine administrative action related to tax withholding rather than a discretionary sale of shares.

Negatives

• Reduction in the direct equity stake held by a senior executive.

Risks

• None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Future Outlook

Not applicable as this is a retrospective disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that routine Form 4 filings regarding tax withholding upon the vesting of equity awards are standard practice for senior executives in the biotechnology sector and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices observed at large-cap pharmaceutical companies like Pfizer, Gilead, and AbbVie, where equity vesting triggers automatic tax withholding.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a non-discretionary tax withholding event.

Key Dates

Keywords

Amgen, AMGN, Insider Trading, Form 4, Executive Compensation, SEC Filing